Navigation Links
New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
Date:11/19/2008

the vast majority of CKD and dialysis patients, a decision that seems primarily driven by cost / reimbursement. Familiarity with Genzyme's Renagel is high, as are perceptions of its performance on the most important phosphate binder attributes, but use of the product tends to be limited to second line therapy. Current share for Shire's Fosrenol is relatively low but Nephrologists project a significant increase in use to close to 10% market share in the dialysis setting in the next six months, with decreases projected for both calcium-based binders and Renagel. Current use of FMC's PhosLo is also low, but Nephrologists expect increases in use among both dialysis and CKD patients in the next six months. Calcium carbonate, however, is expected to remain the go to calcium-based binder with approximately 90% of the calcium business.

About BioTrends Research Group, Inc.

BioTrends Research Group, Inc. (www.bio-trends.com) provides syndicated and custom market research to pharmaceutical manufacturers competing in clinically evolving, specialty pharmaceutical markets. For information on BioTrends publications and research capabilities, please contact us at (610) 363-3872 or www.bio-trends.com.

All company, brand, or product names contained in this document may be trademarks of their respective holders.


'/>"/>
SOURCE BioTrends Research Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Reportlinker Adds Training Manikins - Global Trends 2Reportlinker Adds Training Manikins - Global Trends 3Reportlinker Adds Training Manikins - Global Trends 4Reportlinker Adds Training Manikins - Global Trends 5Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 1Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 2Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 3Nuvilex Cites Study that Suggests Red Yeast Rice an Active Ingredient in Cinnechol Can Help to Improve Cardiovascular Health 49905 4Living Cell Technologies Diabetes Clinical Trial Authorized by New Zealand Government 49902 1Living Cell Technologies Diabetes Clinical Trial Authorized by New Zealand Government 49902 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 1Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 2Dynatronics Begins Shipping New V Force Vibration Therapy Units 49899 3